Pharmacological inhibition of β3 integrin reduces the inflammatory toxicities caused by oncolytic adenovirus without compromising anticancer activity

類似資料

• RAD51 and BRCA2 enhance oncolytic adenovirus type 5 activity in ovarian cancer
  著者:: Tookman, Laura A., 等
  出版事項: (2015)
• Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control
  著者:: Ingemarsdotter, Carin K., 等
  出版事項: (2014)
• Inhibition of the Inflammatory Cytokine TNF-α Increases Adenovirus Activity in Ovarian Cancer via Modulation of cIAP1/2 Expression
  著者:: Salako, Michael A, 等
  出版事項: (2011)
• Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells
  著者:: Connell, Claire M., 等
  出版事項: (2011)
• Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer
  著者:: Ingemarsdotter, C K, 等
  出版事項: (2010)